IP Library › Granted Patent US 11,534,363
Granted Patent B2
US 11,534,363 · App. 17/162,109 · Granted Dec 27, 2022

Modifying humidity and convection to glabrous tissue to control metabolism

Inventor: Mark L. Swyer (Mill Creek, WA)
Assignee: Core Thermal, Inc.
A61H9/0057A61F7/0053A61F7/0085A61F7/02A61H33/06A61H35/00A61H35/006A61F2007/0036A61F2007/0045A61F2007/0057A61F2007/0076A61F2007/0239A61F2007/0258A61H2201/025A61H2201/0207A61H2201/0214A61H2201/5084A61H2205/065A61H2230/045A61H2230/105A61H2230/305A61H2230/505A61H2230/605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,534,363
App. No.
17/162,109
Granted
Dec 27, 2022
Kind
B2
Abstract

Systems and methods for affecting metabolism, such as the treatment of metabolic syndrome are disclosed. A method for treating metabolic syndrome can include one or more of the steps including identifying a region of the patient comprising glabrous tissue; positioning the region of the patient comprising glabrous tissue into an enclosed chamber; adjusting the relative humidity of the enclosed chamber sufficient to create a physiologic metabolic effect; and activating a convection fan within the chamber to promote heat transfer from the glabrous tissue. The method need not involve altering the temperature within the enclosed chamber.

Claims (30)

1. A system for modulating glabrous tissue of a patient, comprising:

a chamber configured to receive a portion of the patient comprising the glabrous tissue;

a compressor configured to supply a gas to an interior of the chamber sufficient to transfer heat away from the glabrous tissue, the gas having a relative humidity of less than about 35%;

a patient port operably connected to the chamber, the patient port configured to allow insertion of the portion of the patient into the chamber and a seal to be formed;

a fan configured to direct gas to the glabrous tissue; and

a controller configured to adjust the relative humidity of the gas,

wherein the system is not configured to alter a temperature or pressure of the interior of the chamber.

2. The system of claim 1 , further comprising a vacuum.

3. The system of claim 1 , further comprising a sensor.

4. The system of claim 1 , wherein the housing comprises a length between 6 inches and 24 inches.

5. The system of claim 1 , wherein the compressor is configured to deliver air, nitrogen, oxygen, helium, or a combination of gases.

6. The system of claim 1 , wherein the controller is further configured to control the rate of flow.

7. The system of claim 1 , wherein the controller is configured to adjust the relative humidity based on an input from one or more sensors.

8. A method for treating a patient, comprising:

inserting a portion of the patient comprising glabrous tissue into a patient port operably connected to a chamber, the patient port forming a seal;

supplying a gas to an interior of the chamber sufficient to transfer heat away from the glabrous tissue, the gas having a relative humidity of less than about 35%; and

directing gas to the glabrous tissue by a fan,

wherein the method does not alter a temperature or pressure of the interior of the chamber.

9. The method of claim 8 , wherein air surrounding the patient outside of the chamber has a higher relative humidity.

10. The method of claim 8 , further comprising adjusting the relative humidity of the gas.

11. The method of claim 8 , wherein the method increases metabolism.

12. The method of claim 8 , wherein the method promotes overall weight loss by enhanced caloric loss.

13. The method of claim 8 , wherein the method improves insulin resistance.

14. The method of claim 8 , wherein the method stimulates adiponectin production.

15. The method of claim 8 , wherein the method increases glucose uptake.

16. The method of claim 8 , wherein the method normalizes lipid metabolism.

17. The method of claim 8 , wherein the method reduces vascular smooth muscle proliferation.

18. The method of claim 8 , wherein the method causes vasodilation and blood pressure reduction.

19. The method of claim 8 , wherein the method triggers lipolysis.

20. The method of claim 8 , wherein the method activates brown adipose tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2021
From: SWYER, MARK L.
To: CORE THERMAL, INC.
Reel/Frame 055896/0702 →
Continuity (4)
Continuation 15677882 · Aug 15, 2017
Continuation 14298732 · Jun 6, 2014
Provisional Application 61832719 · Jun 7, 2013
Related Publication 20210220215A1 · Jul 22, 2021
Cited By (1)
US 1,110,526